SGS Life Science Services adds analytical methods to identify amino acid impurities in bio/pharmaceutical manufacturing at facility in Germany.
SGS Life Science Services has announced that it offers analytical methods, in line with the European Pharmacopoeia (Ph.Eur.), to identify amino acid impurities in bio/pharmaceutical manufacturing at its laboratory in Taunusstein, Germany. The facility is the only contract lab in Germany able to offer these services under GMP, the company reports.
Analysis will be conducted in accordance with Ph.Eur. 2.2.56, Method 1 – Post-Column Ninhydrin Derivatisation, which started in January 2014. Ninhydrin is a reagent used to derivatise amino acids and was traditionally tested using thin layer chromatography, combined with visual and qualitative determination. The newer method, outlined in Ph.Eur.’s most recent edition and employed at the SGS facility, utilizes spectrophotometry and liquid chromatographic techniques for greater resolution and sensitivity.
SGS anticipates that qualification will be completed in March 2015, with the amino acid analytical function fully operational by May 2015. The capabilities in Germany complement SGS’ existing amino acid analytical services provided from its laboratories in Clichy, France, Wavre, Belgium, and Lincolnshire, IL.
Source: SGS Life Science Services
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.